Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse

Journal of Immunology

Volumn 163, Issue 3, 1999, Pages 1696-1703

  Gallichan, W Scott ^a   Balasa, Balaji ^a   Davies, Joanna D ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIGENS; CYTOKINES; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE REARRANGEMENT, BETA-CHAIN T-CELL ANTIGEN RECEPTOR; GLUTAMATE DECARBOXYLASE; IMMUNE TOLERANCE; IMMUNOPHENOTYPING; INTERLEUKIN-4; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; PANCREAS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TH2 CELLS;

EID: 0033179229     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese diabetic strain of mice. Exp. Anim. 29:1.
2. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
3. Anderson, J. T., J. G. Cornelius, A. J. Jarpe, W. E. Winter, and A. B. Peck. 1993. Insulin-dependent diabetes in the NOD mouse model. II. β cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15:113.
4. Daniel, D., Gill, R.G., N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056.
5. + cells correlate with cytokine profile in the spontaneously autoimmune diabetic mouse. Diabetes 45:71.
6. Rabinovitch, A., W. Suarez-Pinzon, A. El-Sheikh, O. Sorensen, and R. F. Power. 1996. Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes 45:749.
7. Fox, C. J., and J. S. Danska. 1997. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158:2414.
8. Pilstrom, B., L. Bjork, and J. Bohme. 1995. Demonstration of a Th1 cytokine profile in the late phase of NOD insulitis. Cytokine 7:806.
9. Berman, M. A., Sandborg C. I., Z. Wang, K. L. Imfeld, F. J. Zaldivar, V. Jadufalza, and B. A. Buckingham. 1996. Decreased IL-4 production in new onset type 1 insulin-dependent diabetes mellitus. J. Immunol. 157:4690.
10. Wilson, S. B., S. C. Kent, K. T. Patton, T. Orban, R. A. Jackson, M. Exley, S. Porcelli, D. A. Schatz, M. A. Atkinson, S. P. Balk, et al. 1998. Extreme Th1 bias of invariant Vα24Jαq T cells in type 1 diabetes. Nature 391:177.
11. Katz, J. D., C. Benoist, and D. Mathis, 1995. T helper cell subsets in insulin-dependent diabetes mellitus. Science 268:1185.
12. Shehadeh, N. N., F. LaRosa, and K. J. Lafferty. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6:291.
13. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:34.
14. Tian, J., M. A. Atkinson, M. Clare-Salzler, A. Herschenfeld, T. Forsthuber, P. V. Lehmann, and D. L. Kaufman. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561.
15. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell 85: 291.
16. Pakala, S. V., M. O. Kurrer, and J. D. Katz. 1997. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186:299.
17. Cameron, M. J., G. A. Areaza, P. Zucker, S. W. Chensue, R. M. Strieter, S. Chakrabarti, and T. L. Delovitch. 1997. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159:4686.
18. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184:1093.
19. Mueller, R., L. M. Bradley, T. Krahl, and N. Sarvetnick. 1997. Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 7:411.
20. Rabinovitch, A., W. L. Suarez-Pinzon, O. Sorensen, R. C. Bleackley, R. F. Power, and R. V. Rajotte. 1995. Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Transplantation 60:368.
21. Tian, J., M. Clare-Salzler, A. Herschenfeld, B. Middleton, D. Newman, R. Mueller, S. Arita, C. Evans, M. A. Atkinson, Y. Mullen, et al. 1996. Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1348.
22. Rapoport, M. J., A. Jaramillo, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska and T. L. Delovitch. 1993. Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med. 178:87.
23. Tominaga, Y., M. Nagata, H. Yasuda, N. Okamoto, K. Arisawa, H. Moriyama, M. Miki, K. Yokono, and M. Kasuga. 1998. Administration of IL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86:209.
24. Inobe, J. I., Y. Chen, and H. L. Weiner. 1996. In vivo administration of IL-4 induces TGF-β-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci. 778:390.
25. Zipris, D., A. H. Lazarus, A. R. Crow, M. Hadzija, and T. L. Delovitch. 1991. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. J. Immunol. 146:3763.
26. Kaufman, D. L., M. Clare-Salzler, J. Tian, T. Forsthuber, G. S. P. Ting, P. Robinson, M. A. Atkinson, E. E. Sercarz, A. J. Tobin, and P. V. Lehmann. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69.
27. Tisch, R., X. D. Yang, S. M. Singer, R. S. Liblau, L. Fugger, and H. O. McDevitt. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72.
28. Gallichan, W. S., T. Kafri, T. Krahl, I. M. Verma, and N. Sarvetnick. 1998. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. 9:2717.
29. Balasa, B., J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick. 1998. IL-10 impacts autoimmune diabetes via a CD8 T cell pathway circumventing the requirement for CD4 T and B lymphocytes. J. Immunol. 161:4420.
30. Davies, J. D., G. Martin, J. Phillips, S. E. Marshall, S. P. Cobbold, and H. Waldmann. 1996. T cell regulation in adult transplantation tolerance. J. Immunol. 157:529.
31. Balasa, B., C. Deng, J. Lee, P. Christadoss, and N. Sarvetnick. 1998. The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. J. Immunol. 161:2856.
32. Zechel, M. A., J. F. Elliott, M. A. Atkinson, and B. Singh. 1998. Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11:83.
33. Wood, S., T. Roa, and A. Frey. 1999. Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4. Cell. Immunol. 192:1.
34. Elias, D., A. Meilin, V. Ablamunits, O. S. Birk, P. Carmi, S. Konen-Waisman, and I. R. Cohen. 1997. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 46:758.
35. Tisch, R., R. S. Liblau, X. D. Yang, P. Liblau, and H. O. McDevitt. 1998. Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894.
36. Tian, J., and D. L. Kaufman. 1998. Attenuation of inducible Th2 immunity with autoimmune disease progression. J. Immunol. 161:5399.
37. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331.
38. Rapoport, M. J., A. Mor, P. Vardi, Y. Ramot, R. Winker, A. Hinki and T. Bistritzer. 1998. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J. Autoimmun. 11: 635.
39. 7-dependent reaction. Proc. Natl. Acad. Sci. USA 95:1721.
40. Lafaille, J. J., F. V. Keere, A. L. Hsu, J. L. Baron, W. Haas, C. S. Raine, and S. Tonegawa. 1997. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J. Exp. Med. 186:307.
41. - thymocytes J. Exp. Med. 189:279.
42. Moritani, M., K. Yoshimoto, S. F. Wong, C. Tanaka, T. Yamaoka, T. Sano, Y. Komagata, J. Miyazaki, H. Kikutani, and M. Itakura. 1998. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-β. J. Clin Invest. 102:499.
43. + T cells: IL-4 and IFN-β have opposing effects, while TGF-β positively regulates its own production. J. Immunol. 160:5719.
44. Zheng, X. X., A. W. Steele, W. W. Hancock, A. C. Stevens, P. W. Nickerson, P. Roy-Chaudhury, Y. Tian, and T. B. Strom. 1997. A noncytolytic IL-10Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J. Immunol. 158:4507.
45. Wang, B., A. Gonzalez, P. Hoglund, J. D. Katz, C. Benoist, and D. Mathis. 1998. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47:1207.
46. Hultgren, B., X. Huang, N. Dybdal, and T. A. Stewart. 1996. Genetic absence of γ-interferon delays but does not prevent diabetes in NOD mice. Diabetes 45:812.
47. Ploix, C., I. Bergerot, N. Fabien, S. Perche, V. Moulin, and C. Thivolet. 1998. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T cells in the pancreas and pancreatic lymph nodes. Diabetes 47:39.
48. Polanski, M., N. S. Melican, J. Zhang, and H. L. Weiner. 1997. Oral administration of the immunodominant β-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10:339.
49. Hancock, W. W., M. Polanski, J. Zhang, N. Blogg, and H. L. Weiner. 1995. Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-β, and prostaglandin-E. Am. J. Pathol. 147:1193.
50. Lee, M.-S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.